On 16th March 2025, the Australian Government increased the range of pharmaceuticals listed on the Pharmaceutical Benefits Scheme to offer more choice for lower cost. The focus was on contraception, Endometriosis and IVF medicines.
This is in addition to the announcement in February 2025 when $573.3 million was committed to women’s health in Australia, to deliver “more choice, lower costs and better health care for women”.
“Women have asked government to take their health care seriously, and we have listened.” The Hon Mark Butler MP, Minister for Health and Aged Care.
“The Albanese Labor Government is not slowing down on women’s health. No matter what stage of life you’re at, your healthcare is front and centre.” The Hon Ged Kearney MP, Assistant Minister for Health and Aged Care.
The listed treatments:
Contraceptive
Slinda® (Drospirenone)has been listed as new contraceptive option and is a progestogen-only-pill that may be used by over 100,000 women who don’t respond well to contraceptives with estrogens.
Endometriosis
Over 8,500 women will now have access to a new endometriosis treatment medicine. Ryeqo® (Relugolix with estradiol and with norethisterone) is a medicine option for those who don’t have success with relief of symptoms with the use of hormonal treatment or pain relief.
IVF
Now, four combination therapy Pergoveris® (follitropin alfa with lutropin alfa) pens per script will be available under one patient co-payment (increased from 2) for over 6,000 women annually who require up to four pens to complete an IVF cycle. It will also now be available in the earlier phase of IVF treatment.
For additional information from the Government check out these links:
For additional reports relating to this release check out these sources:
Please note; these views are not political, or personal, and are simply a representation of the Australian Government’s announcement. *Information gathered from Minister Butler’s Press Release 16th March 2025.
Author: livingwithsupport
This information is for educational and exploration purposes only and is not medical advice. Please consult your medical professional for advice on your personal situation.